TriSalus Life Sciences, Inc. is an oncology-focused medical technology company that develops innovative drug delivery technologies for solid tumors. Its flagship product, the TriNav Infusion System, uses Pressure-Enabled Drug Delivery (PEDD) technology for interventional radiology procedures including TACE and TARE. The company also develops nelitolimod, an investigational TLR9 agonist, and the PRVI device for pancreatic tumor treatment, generating $45.2 million in TriNav revenue in 2025.
Q2 FY2026 — expected 2026-09-23
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-05 | 2025-12-31 | 0001628280-26-015163 | EDGAR | 85K words |
| 2025-04-15 | 2024-12-31 | 0001826667-25-000030 | EDGAR | — |
| 2024-04-11 | 2023-12-31 | 0001826667-24-000005 | EDGAR | — |
| 2023-03-22 | 2022-12-31 | 0001410578-23-000332 | EDGAR | — |
| 2022-03-03 | 2021-12-31 | 0001410578-22-000252 | EDGAR | — |
| 2021-03-31 | 2020-12-31 | 0001104659-21-044719 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001628280-25-052043 | EDGAR | 25K words |
| 2025-08-12 | 2025-06-30 | 0001826667-25-000117 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0001826667-25-000051 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0001826667-24-000051 | EDGAR | — |
| 2024-08-14 | 2024-06-30 | 0001826667-24-000039 | EDGAR | — |
| 2024-05-15 | 2024-03-31 | 0001826667-24-000017 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0001826667-23-000007 | EDGAR | — |
| 2023-08-02 | 2023-06-30 | 0001410578-23-001525 | EDGAR | — |
| 2023-05-12 | 2023-03-31 | 0001410578-23-001035 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001410578-22-003118 | EDGAR | — |
| 2022-08-10 | 2022-06-30 | 0001410578-22-002206 | EDGAR | — |
| 2022-05-11 | 2022-03-31 | 0001410578-22-001311 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-05 | 0001628280-26-015155 | EDGAR | 5K words |
| 2026-02-20 | 0001493152-26-007598 | EDGAR | — |
| 2026-02-09 | 0001628280-26-006219 | EDGAR | — |
| 2026-01-12 | 0001628280-26-001743 | EDGAR | — |
| 2025-11-13 | 0001628280-25-052008 | EDGAR | — |
| 2025-10-01 | 0001628280-25-043440 | EDGAR | — |
| 2025-08-29 | 0001826667-25-000129 | EDGAR | — |
| 2025-08-12 | 0001826667-25-000115 | EDGAR | — |
| 2025-07-24 | 0001826667-25-000103 | EDGAR | — |
| 2025-06-23 | 0001826667-25-000077 | EDGAR | — |
128 total filings indexed. 100 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001826667 |
| Ticker | TLSI |
| Exchange | Nasdaq |
| SIC | 3841: Surgical & Medical Instruments & Apparatus |
| Incorporated | DE |
| Website | https://www.trisaluslifesci.com |
| Listed | 2023-08-11 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report